Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Product Launch

24 May 2005 06:00

Embargoed Release: 07:00hrs Tuesday 24 May 2005 SOPHEON PLC (`Sopheon' or `the Company') SOPHEON INTRODUCES ACCOLADE VERSION 6.0 New release extends Sopheon's market leadership In enabling successful adoption of best-practice new product development process Sopheon, the international software and services company, today introduced thelatest version of its flagship Sopheon Accolade‚® product portfolio and processmanagement system. Based on extensive research involving customers, partnersand industry experts, the nearly 30 new features being introduced in Accolade6.0 are focused on eliminating the administrative, communication andknowledge-sharing impediments to successful adoption of best practice productdevelopment process methodology, and improving the quality and efficiency ofportfolio decision-making. They include: * Dashboard on the Desktop - integrates Accolade with the user's existing personal productivity tools. Reduces one-off training, avoids duplication in administrative tasks and reduces need for behavioral change. * Instant deliverables - helps create gate-meeting presentations, reports and other process-related materials in minutes, freeing up time to focus on the intellectual and strategic challenges of product development. * Enhanced portal access - makes it possible for users to find and retrieve information related to their projects without having to look inside multiple applications. * Alignment monitoring - easy evaluation of how well day-to-day project activities align with the performance standards and strategic priorities of the organization. Dr Robert Cooper, president of the Product Development Institute and developerof the Stage-Gate‚® product development methodology, said: "One of Accolade'sprincipal strengths is the way in which it clearly, simply lays down the stepsof the Stage-Gate‚® process, automates them, and takes the administrative burdenout of executing them. These advantages encourage team members and executivestakeholders to try the system. When they do, they quickly see its value, andtrial turns into adoption. Many of the features being introduced in this latestversion of Accolade will reduce the time and effort needed to successfullyimplement Stage-Gate‚®. Accolade will help ensure that your process is reallyused."One of Sopheon's central goals in continuing to evolve Accolade is to createthe most user-friendly, efficient product development environment possible.This includes looking for ways to link Accolade to productivity tools that arealready available and familiar to Accolade users. For example, key aspects ofthe enhanced functionality being introduced in Accolade 6.0 were created byintegrating widely used Microsoft technologies, including Microsoft‚® OfficeProject Server 2003 and SharePoint‚® Portal Server 2003. "We initially choseSopheon as a partner in our collaborative product development initiativebecause we recognized that they are the industry leader in expertise andsolutions related to product portfolio and process management," said Tim Low,senior product manager, Microsoft. "What excites us about the partnership todayis that it has resulted in an application that uniquely and effectively focusesMicrosoft technology on the critical front-end of the product developmentprocess and the challenge of product innovation. With tight integration to theMicrosoft‚® Office Enterprise Project Management platform and SharePoint‚® PortalServer 2003, Accolade 6.0 gives product development teams and executives theability to access and share project-related information from enterprise-widesystems and use that data to make faster, better portfolio managementdecisions."Parker Hannifin, the $7 billion global market leader in motion and controlsystems, has a first-hand perspective on the positive impact that Accolade canhave on process implementation success. "One of the principal reasons weselected Accolade was our belief that it would help ensure successful adoptionacross 122 business units and 8 operating divisions," said Bob McAdoo, directorof IT applications for Parker. "We rolled out Accolade six months ago inconjunction with the introduction of our Stage-Gate‚® process. Not only is thesystem being used, adoption levels companywide have exceeded our expectations.With the enhancements being introduced in the newest version of Accolade, weexpect use rates to continue to escalate."Other industry leaders such as BASF, Cadbury Schweppes, GlaxoSmithKline,Revlon, Cargill, and Pfizer, as well as a broad mix of mid-market companies,have implemented Accolade to improve innovation, cut product development wasteand accelerate idea-to-commercialization cycles. Users have reported achievingup to 40% increases in revenue from new products and 20-30% reductions intime-to-market.For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor Van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010About SopheonSopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development (PD) processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time to market. Sopheon is listed on the AIM market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.Sopheon Accolade‚® is a registered trademark of Sopheon plc.Stage-Gate‚® is a registered trademark of the Product Development Institute,Inc.Microsoft‚® and SharePoint‚® are registered trademarks of Microsoft Corporation.All other trademarks are the sole property of their respective ownersENDSOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.